Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2022
Historique:
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 8 3 2022
Statut: epublish

Résumé

The commercial health insurance market is characterized by consistently high enrollee turnover. Turnover can disrupt care continuity for patients and create challenges for insurers in managing the health of their enrollee populations. Yet the extent to which enrollees reenroll is not widely known. To characterize rates of disenrollment (hereafter, external turnover) and reenrollment in commercial health plans. In this retrospective longitudinal cohort study, trends in turnover and reenrollment in commercial health plans between January 1, 2006, and August 31, 2018, were analyzed. Data analysis was conducted from January 21, 2020, through December 23, 2021. Participants included 3 018 633 primary members and their dependents with employer-sponsored coverage. Primary outcomes included external turnover from commercial coverage and subsequent reenrollment into any line of business with the insurer (commercial, Medicaid Managed Care, and Medicare Advantage). Within commercial coverage, external turnover was analyzed separately for group (ie, employer-sponsored) and individual markets. In the sample of 3 018 633 members, 50.2% were men; mean (SD) age, including dependents, was 30.68 (19.05) years. A total of 2.2% of members experienced external turnover each month and 21.5% experienced external turnover each year. The individual market had the highest average monthly turnover rate of 3.4% compared with 2.1% in the group market. December had the highest rate of external turnover, with 13.8% experiencing external turnover in the individual market and 6.9% of members experiencing external turnover in the group market. Fourteen percent of the members who left the insurer from an individual plan reenrolled with the insurer after 1 year, and 34% had reenrolled after 5 years. Among members who left the insurer from a group plan, 12% reenrolled after 1 year and 32% reenrolled after 5 years. After 10 years, reenrollment reached 47% in the 2 markets. More than 80% of enrollees returned to the same line of business and within the same state, suggesting findings may generalize to smaller insurers. The findings of this cohort study suggest that insurers may benefit from investing in members' long-term health outcomes despite substantial short-term turnover rates.

Identifiants

pubmed: 35201308
pii: 2789399
doi: 10.1001/jamanetworkopen.2022.0320
pmc: PMC8874349
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e220320

Références

Am Econ Rev. 2011 Dec;101(7):3047-77
pubmed: 29517886
Health Aff (Millwood). 2020 Jan;39(1):85-93
pubmed: 31905055
J Health Econ. 2002 Jan;21(1):89-116
pubmed: 11845927
Health Aff (Millwood). 2016 Oct 1;35(10):1816-1824
pubmed: 27702954
Am Econ Rev. 2012 Apr;102(2):1161-85
pubmed: 29521483
J Gen Intern Med. 2017 Oct;32(10):1146-1155
pubmed: 28523475
Am Econ Rev. 2015 Jan;105(1):204-33
pubmed: 29542312
JAMA Intern Med. 2019 Apr 1;179(4):524-532
pubmed: 30801625
Q J Econ. 2012;127(1):199-235
pubmed: 22454838
Am Econ Rev. 2015 Aug;105(8):2449-500
pubmed: 29546969
Health Econ. 2010 Apr;19(4):438-48
pubmed: 19353530
Am Econ Rev. 2013 Dec;103(7):2643-82
pubmed: 29533561
Health Aff (Millwood). 2011 Feb;30(2):228-36
pubmed: 21289343
Health Aff (Millwood). 2000 May-Jun;19(3):158-64
pubmed: 10812794
Inquiry. 2005 Fall;42(3):255-65
pubmed: 16353762

Auteurs

Hanming Fang (H)

Department of Economics, University of Pennsylvania, Philadelphia.

Molly Frean (M)

Analysis Group, Boston, Massachusetts.

Gosia Sylwestrzak (G)

Anthem Inc, Wilmington, Delaware.

Benjamin Ukert (B)

Anthem Inc, Wilmington, Delaware.
Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH